Verapamil hydrochloride extended-release tablets are administered to lower high blood pressure, reducing the risk of serious cardiovascular conditions such as strokes and heart attacks. Shares of Zydus Lifesciences Ltd ended at ₹927.50, up by ₹0.90, or 0.097%, on the BSE today, November 25.
